English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2350]
News [4892]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy
Breast cancer patients with higher BMI more likely to experience heart damage during chemotherapy
Novel, non-invasive DNA methylation assay shows promise for detection of multiple GI cancers, according to new study in China
Novel, non-invasive DNA methylation assay shows promise for detection of multiple GI cancers, according to new...
FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer
FDA approves dostarlimab-gxly with chemotherapy for endometrial cancer
Researcher to lead first-ever international liquid biopsy retinoblastoma study
Researcher to lead first-ever international liquid biopsy retinoblastoma study
AI drives new era of target identification and drug design
AI drives new era of target identification and drug design
67 percent of vaccinated Brazilian women had a cervical screening test
67 percent of vaccinated Brazilian women had a cervical screening test
Researchers identify two new subtypes of HPV-associated head and neck cancers
Researchers identify two new subtypes of HPV-associated head and neck cancers
Maintenance therapy with selinexor may extend progression-free survival for some endometrial cancer patients
Maintenance therapy with selinexor may extend progression-free survival for some endometrial cancer patients
Novel bispecific antibodies talquetamab and teclistamab receives positive CHMP opinions for the treatment of relapsed and refractory multiple myeloma
Novel bispecific antibodies talquetamab and teclistamab receives positive CHMP opinions for the treatment of...
FDA approves quizartinib for newly diagnosed acute myeloid leukaemia
FDA approves quizartinib for newly diagnosed acute myeloid leukaemia
<1...7374757677...490>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top